Li J, Chan MC, Yu Y, Bei Y, Chen P, Zhou Q, Cheng L, Chen L, Ziegler O, Rowe GC, Das S, Xiao J (2017) miR-29b contributes to multiple types of muscle atrophy
doi: 10.1165/ajrcmb/3.1.79
This decision marks an important turning point for patients who allege that GLP-1 drugs caused sudden optic nerve damage and irreversible blindness
Weight Loss Efficacy and Comparative Effectiveness Superior Performance of Dual-Agonist Therapies The SURMOUNT-5 head-to-head trial represents a landmark study comparing the two leading GLP-1 medications directly ^2
Many patients taking GLP-1 receptor agonists for diabetes or weight management report improvements in joint pain, prompting questions about whether these medications directly address musculoskeletal symptoms
Even if the label on your vial says the medication is good for 90 days, that timeframe often changes the moment you insert a needle into the rubber stopper